About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 185646, 5 pages
http://dx.doi.org/10.1155/2011/185646
Research Article

Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial

1Institute of Oncology, Zaloska 2, 1000 Ljubljana, Slovenia
2School of Medicine, University of maribor, Slomskov trg 15, 2000 Maribor, Slovenia
3University Hospital for Pulmonary and Allergic Diseases, Golnik, Slovenia

Received 31 October 2010; Accepted 21 February 2011

Academic Editor: Tony Mok

Copyright © 2011 Matjaz Zwitter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Matjaz Zwitter, Mirjana Rajer, Viljem Kovac, Izidor Kern, Martina Vrankar, and Uros Smrdel, “Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 185646, 5 pages, 2011. doi:10.1155/2011/185646